OCT4 Expression in Gliomas Is Dependent on Cell Metabolism
Andrey Volnitskiy1, Konstantin Shabalin1, Rimma Pantina1
1Petersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Orlova Roscha 1, 188300 Gatchina, Russia.
OCT4 expression is present in malignant gliomas but not normal brain tissue, suggesting a role in oncogenesis. Its expression is linked to metabolic reprogramming, specifically α-ketoglutarate levels.
Area of Science:
- Oncology
- Molecular Biology
- Neuroscience
Background:
- The transcription factor OCT4 is crucial for early embryogenesis and induced pluripotent stem cell formation.
- The precise role of OCT4 in oncogenesis, particularly in malignant gliomas, remains unclear.
Purpose of the Study:
- To investigate OCT4 expression in malignant gliomas.
- To explore the regulatory mechanisms of OCT4 in glioma cells.
Main Methods:
- Analysis of OCT4 expression in twenty glioma cell lines and normal adult brain tissue.
- OCT4 knockdown experiments in glioma cell lines.
- Culturing glioma cells under varying conditions (serum-free, L-glutamine-free) and assessing OCT4 expression.
- Nuclear Magnetic Resonance (NMR) to analyze the Krebs cycle.
Main Results:
- OCT4 expression was detected in all tested glioma cell lines but absent in normal brain tissue.
- OCT4 knockdown led to tumor cell death in one cell line.
- Serum-free and L-glutamine-free conditions significantly increased OCT4 expression.
- Data suggests a link between OCT4 regulation and α-ketoglutarate (α-KG) dependent metabolic reprogramming.
Conclusions:
- OCT4 is a potential marker for malignant gliomas.
- Glioma cell metabolism, particularly α-KG availability, may regulate OCT4 expression.
More Related Videos
05:45Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
